The Extracellular Matrix Regulates Granuloma Necrosis in Tuberculosis

Journal of Infectious Diseases

Volumn 212, Issue 3, 2015, Pages 463-473

  Al Shammari, Basim ^a   Shiomi, Takayuki ⁱ   Tezera, Liku ^g   Bielecka, Magdalena K ^g   Workman, Victoria ^d,e,f   Sathyamoorthy, Tarangini ^a   Mauri, Francesco ^b   Jayasinghe, Suwan N ^d,e,f   Robertson, Brian D ^c   D'Armiento, Jeanine ⁱ   Friedland, Jon S ^a   Elkington, Paul T ^a,g,h  

^a Hammersmith Campus   (United Kingdom)

^b Haematology Research Centre   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d BioPhysics Group   (United Kingdom)

^e Institute of Biomedical Engineering   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g Clinical and Experimental Sciences Academic Unit   (United Kingdom)

^h UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

ⁱ Howard Hughes Medical Institute   (United States)

Author keywords

extracellular matrix; immunopathology; matrix metalloprotease; tuberculosis

Indexed keywords

COLLAGEN; INTERSTITIAL COLLAGENASE; MMP1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACTERIAL SURVIVAL; CELL COUNT; CELL DEATH; CELL VIABILITY; COLLAGEN DEGRADATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; HOST PATHOGEN INTERACTION; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; IN VITRO STUDY; INVESTIGATIVE PROCEDURES; LACTATE DEHYDROGENASE RELEASE ASSAY; LUNG GRANULOMA; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROPIDIUM IODIDE STAINING; PROTEIN EXPRESSION; TUBERCULOSIS; WILD TYPE; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CHEMISTRY; GENETICS; GRANULOMA; LUNG; LUNG TUMOR; METABOLISM; MICROBIOLOGY; NECROSIS; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; COLLAGEN; EXTRACELLULAR MATRIX; GRANULOMA; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 1; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NECROSIS; TUBERCULOSIS;

EID: 84930317830     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv076     Document Type: Conference Paper

References (50)

1. Tameris MD, Hatherill M, Landry BS, et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial. Lancet 2013; 381:1021-8.
2. Johnson JL, Hadad DJ, Dietze R, et al. Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion. Am J Respir Crit Care Med 2009; 180:558-63.
3. Zumla A, Hafner R, Lienhardt C, Hoelscher M, Nunn A. Advancing the development of tuberculosis therapy. Nat Rev Drug Discov 2012; 11: 171-2.
4. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009; 27:393-422.
5. Barry CE III, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009; 7:845-55.
6. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol 2013; 31:475-527.
7. Cooper AM, Torrado E. Protection versus pathology in tuberculosis: recent insights. Curr Opin Immunol 2012; 24:431-7.
8. Uhlin M, Andersson J, Zumla A, Maeurer M. Adjunct immunotherapies for tuberculosis. J Infect Dis 2012; 205(suppl 2):S325-34.
9. Kaufmann SH. Future vaccination strategies against tuberculosis: Thinking outside the box. Immunity 2010; 33:567-77.
10. Dye C, Williams BG. The population dynamics and control of tuberculosis. Science 2010; 328:856-61.
11. Russell DG, Barry CE III, Flynn JL. Tuberculosis: what we don't know can, and does, hurt us. Science 2010; 328:852-6.
12. Dannenberg AM Jr, Sugimoto M. Liquefaction of caseous foci in tuberculosis. Am Rev Respir Dis 1976; 113:257-9.
13. Young D. Animal models of tuberculosis. Eur J Immunol 2009; 39: 2011-4.
14. Calderon VE, Valbuena G, Goez Y, et al. A humanized mouse model of tuberculosis. PLoS One 2013; 8:e63331.
15. Pan H, Yan BS, Rojas M, et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature 2005; 434:767-72.
16. Park DY, Kim JY, Choi KU, et al. Comparison of polymerase chain reaction with histopathologic features for diagnosis of tuberculosis in formalin-fixed, paraffin-embedded histologic specimens. Arch Pathol Lab Med 2003; 127:326-30.
17. Elkington P, Shiomi T, Breen R, et al. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest 2011; 121:1827-33.
18. Krishnan N, Malaga W, Constant P, et al. Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles. PLoS One 2011; 6: e23870.
19. Elkington PT, Green JA, Friedland JS. Filter sterilization of highly infectious samples to prevent false negative analysis of matrix metalloproteinase activity. J Immunol Methods 2006; 309:115-9.
20. Puissegur MP, Botanch C, Duteyrat JL, Delsol G, Caratero C, Altare F. An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. Cell Microbiol 2004; 6:423-33.
21. Workman VL, Tezera LB, Elkington PT, Jayasinghe SN. Controlled generation of microspheres incorporating extracellular matrix fibrils for three-dimensional cell culture. Adv Funct Mater 2014; 24:2648-57.
22. Lemaitre V, O'Byrne TK, Borczuk AC, Okada Y, Tall AR, D'Armiento J. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest 2001; 107:1227-34.
23. Puissegur MP, Lay G, Gilleron M, et al. Mycobacterial lipomannan induces granuloma macrophage fusion via a TLR2-dependent, ADAM9-and beta1 integrin-mediated pathway. J Immunol 2007; 178:3161-9.
24. Schwartz MA, Chen CS. Cell biology. Deconstructing dimensionality. Science 2013; 339:402-4.
25. Meredith JE Jr, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993; 4:953-61.
26. Kubler A, Luna B, Larsson C, et al. Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation. J Pathol 2015; 235:431-44.
27. Elkington PT, D'Armiento JM, Friedland JS. Tuberculosis immunopathology: The neglected role of extracellular matrix destruction. Sci Transl Med 2011; 3:71ps6.
28. Davidson JM. Biochemistry and turnover of lung interstitium. Eur Respir J 1990; 3:1048-63.
29. Sorokin L. The impact of the extracellular matrix on inflammation. Nat Rev Immunol 2010; 10:712-23.
30. Newman SL, Gootee L, Kidd C, Ciraolo GM, Morris R. Activation of human macrophage fungistatic activity against Histoplasma capsulatum upon adherence to type 1 collagen matrices. J Immunol 1997; 158: 1779-86.
31. Merline R, Moreth K, Beckmann J, et al. Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal 2011; 4:ra75.
32. Lock R, Debnath J. Extracellular matrix regulation of autophagy. Curr Opin Cell Biol 2008; 20:583-8.
33. Buchheit CL, Rayavarapu RR, Schafer ZT. The regulation of cancer cell death and metabolism by extracellular matrix attachment. Semin Cell Dev Biol 2012; 23:402-11.
34. Behar SM, Divangahi M, Remold HG. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat Rev Microbiol 2010; 8:668-74.
35. Moro L, Venturino M, Bozzo C, et al. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. Embo J 1998; 17:6622-32.
36. de Fougerolles AR, Chi-Rosso G, Bajardi A, Gotwals P, Green CD, Koteliansky VE. Global expression analysis of extracellular matrixintegrin interactions in monocytes. Immunity 2000; 13:749-58.
37. Kim MJ, Wainwright HC, Locketz M, et al. Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med 2010; 2:258-74.
38. Mehra S, Pahar B, Dutta NK, et al. Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas. PLoS One 2010; 5:e12266.
39. Eum SY, Kong JH, Hong MS, et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 2010; 137:122-8.
40. Elkington PT, Emerson JE, Lopez-Pascua LD, et al. Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch. J Immunol 2005; 175:5333-40.
41. Bifani P, Moghazeh S, Shopsin B, Driscoll J, Ravikovitch A, Kreiswirth BN. Molecular characterization of Mycobacterium tuberculosis H37Rv/ Ra variants: distinguishing the mycobacterial laboratory strain. J Clin Microbiol 2000; 38:3200-4.
42. Via LE, Lin PL, Ray SM, et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 2008; 76:2333-40.
43. Dastur DK, Dave UP. Ultrastructural basis of the vasculopathy in and around brain tuberculomas. Possible significance of altered basement membrane. Am J Pathol 1977; 89:35-50.
44. Lee YA, Choi HM, Lee SH, et al. Hypoxia differentially affects IL-1betastimulated MMP-1 and MMP-13 expression of fibroblast-like synoviocytes in an HIF-1alpha-dependent manner. Rheumatology (Oxford) 2012; 51:443-50.
45. Volkman HE, Pozos TC, Zheng J, Davis JM, Rawls JF, Ramakrishnan L. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 2010; 327:466-9.
46. Thuong NT, Dunstan SJ, Chau TT, et al. Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog 2008; 4:e1000229.
47. De Groote MA, Nahid P, Jarlsberg L, et al. Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment. PLoS One 2013; 8:e61002.
48. Sellors TH. The results of thoracoplasty in pulmonary tuberculosis. Thorax 1947; 2:216-23.
49. Jamieson AM, Pasman L, Yu S, et al. Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 2013; 340:1230-4.
50. Mayer-Barber KD, Andrade BB, Oland SD, et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 2014; 511:99-103.